ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 343378 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 343378; 2) Community: the network communities that were significantly associated with the response to NSC 343378; 3) Molecule: the relationships between components within communities and NSC 343378; 4) MDR: the compounds that were significantly associated with the NSC 343378.

NSC Compound Enrichment Correlation
NSC 719715 Null 0.0201565205286438 0.11554807
NSC 721049 7Z-Plakortide H 0.0201565205286438 -0.0058517571
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.0201565205286438 -0.085070946
NSC 728038 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline 0.0201565205286438 0.095092261
NSC 730868 (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one 0.0201565205286438 -0.01250626
NSC 733504 Everolimus 0.0201565205286438 0.098365145
NSC 736157 Null 0.0201565205286438 -0.060886385
NSC 736802 Null 0.0201565205286438 0.045212383
NSC 737757 2-(4-((oxiran-2-yl)methoxy)styryl)-4,5-dihydrooxazole 0.0201565205286438 0.031587181
NSC 740 Methotrexate 0.0201565205286438 0.02041552
Total:140  Current:71    [First] [Prev] [Next] [Last]